The prevalence of multiple drug resistant urinary tract infections

References

1. 1.↵
   1. Ramírez-Castillo FY,
   2. Moreno-Flores AC,
   3. Avelar-González FJ,
   4. Márquez-Díaz F,
   5. Harel J,
   6. Guerrero-Barrera AL

   . An evaluation of multidrug-resistant Escherichia coli isolates in urinary tract infections from Aguascalientes, Mexico: cross-sectional study. Ann Clin Microbiol Antimicrob 2018; 17: 34.

   OpenUrl
2. 2.↵
   1. Bhatt CP,
   2. Shrestha B,
   3. Khadka S,
   4. Swar S,
   5. Shah B,
   6. Pun K

   . Etiology of urinary tract infection and drug resistance cases of uropathogenes. J Kathmandu Med Coll 2012; 1: 114–120.

   OpenUrl
3. 3.↵
   1. Dehbanipour R,
   2. Rastaghi S,
   3. Sedighi M,
   4. Maleki N,
   5. Faghri J

   . High prevalence of multidrug-resistance uropathogenic Escherichia coli strains, Isfahan, Iran. J Nat Sci Biol Med 2016; 7: 22–26.

   OpenUrl
4. 4.↵
   1. Stewardson AJ,
   2. Vervoort J,
   3. Adriaenssens N,
   4. Coenen S,
   5. Godycki-Cwirko M,
   6. Kowalczyk A, et al.

   Effect of outpatient antibiotics for urinary tract infections on antimicrobial resistance among commensal Enterobacteriaceae: a multinational prospective cohort study. Clin Microbiol Infect 2018; 24: 972–979.

   OpenUrlCrossRefPubMed
5. 5.↵
   1. Teillant A,
   2. Gandra S,
   3. Barter D,
   4. Morgan DJ,
   5. Laxminarayan R

   . Potential burden of antibiotic resistance on surgery and cancer chemotherapy antibiotic prophylaxis in the USA: a literature review and modelling study. Lancet Infect Dis 2015; 15: 1429–1437.

   OpenUrlCrossRefPubMed
6. 6.↵
   1. Woldemariam HK,
   2. Geleta DA,
   3. Tulu KD,
   4. Aber NA,
   5. Legese MH,
   6. Fenta GM, et al.

   Common uropathogens and their antibiotic susceptibility pattern among diabetic patients. BMC Infect Dis 2019; 19: 43.

   OpenUrl
7. 7.↵
   1. Flores-Mireles AL,
   2. Walker JN,
   3. Caparon M,
   4. Hultgren SJ

   . Urinary tract infections: epidemiology, mechanisms of infection, and treatment options. Nat Rev Microbiol 2015; 13: 269–284.

   OpenUrlCrossRefPubMed
8. 8.↵
   1. Gajdács M,
   2. Burián K,
   3. Terhes G

   . Resistance levels and epidemiology of non-fermenting gram-negative bacteria in urinary tract infections of inpatients and outpatients (RENFUTI): a 10-year epidemiological snapshot. Antibiotics (Basel) 2019; 8: 143.

   OpenUrl
9. 9.↵
   1. Gupta K,
   2. Hooton TM,
   3. Naber KG,
   4. Wullt B,
   5. Colgan R,
   6. Miller LG, et al.

   International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 2011; 52: e103–e120.

   OpenUrlCrossRefPubMedWeb of Science
10. 10.↵
    1. Kazmi S,
    2. Noor A,
    3. Noor N,
    4. Khan SZEB

    , Jalal-ud-din MIR, Qayyum U. Drug sensitivity pattern among patients with urinary tract infection: cross sectional study. PJMHS 2021; 15: 1118–1120.

    OpenUrl
11. 11.↵
    1. Moges F,
    2. Mengistu G,
    3. Genetu A

    . Multiple drug resistance in urinary pathogens at Gondar College of Medical Sciences Hospital, Ethiopia. East Afr Med J 2002; 79: 415–419.

    OpenUrlPubMed
12. 12.↵
    1. Ahmad S

    . Multiple drug resistance pattern in urinary tract infection patients in Saudi Arabia. BJID 2019; 6: 3–7.

    OpenUrl
13. 13.↵
    1. Tenney J,
    2. Hudson N,
    3. Alnifaidy H,
    4. Li JTC,
    5. Fung KH

    . Risk factors for aquiring multidrug-resistant organisms in urinary tract infections: a systematic literature review. Saudi Pharm J 2018; 26: 678–684.

    OpenUrl
14. 14.↵
    1. Gordon KA,
    2. Jones RN

    . Susceptibility patterns of orally administered antimicrobials among urinary tract infection pathogens from hospitalized patients in North America: comparison report to Europe and Latin America. Results from the SENTRY Antimicrobial Surveillance Program (2000). Diagn Microbiol Infect Dis 2003; 45: 295–301.

    OpenUrl
15. 15.↵
    1. Farrell DJ,
    2. Morrissey I,
    3. De Rubeis D,
    4. Robbins M,
    5. Felmingham D

    . A UK multicentre study of the antimicrobial susceptibility of bacterial pathogens causing urinary tract infection. J Infect 2003; 46: 94–100.

    OpenUrlCrossRefPubMedWeb of Science
16. 16.↵
    1. Johansen TE,
    2. Cek M,
    3. Naber KG,
    4. Stratchounski L,
    5. Svendsen MV,
    6. Tenke P

    . Hospital acquired urinary tract infections in urology departments: pathogens, susceptibility, and use of antibiotics. Data from the PEP and PEAP-studies. Int J Antimicrob Agents 2006; 28: S91–S107.

    OpenUrlCrossRefPubMed
17. 17.↵
    1. Warren JW,
    2. Tenney JH,
    3. Hoopes JM,
    4. Muncie HL,
    5. Anthony WC

    . A prospective microbiologic study of bacteriuria in patients with chronic indwelling urethral catheters. J Infect Dis 1982; 146: 719–723.

    OpenUrlCrossRefPubMedWeb of Science
18. 18.↵
    1. Cohen-Nahum K,
    2. Saidel-Odes L,
    3. Riesenberg K,
    4. Schlaeffer F,
    5. Borer A

    . Urinary tract infections caused by multi-drug resistant Proteus mirabilis: risk factors and clinical outcomes. Infection 2010; 38: 41–46.

    OpenUrlCrossRefPubMed